Get started
Author

Nagarajan Janaki Sankarachari Krishnan

Observed name: NAGARAJAN JANAKI SANKARACHARI KRISHNAN
ORCID: 0000-0003-4569-1071
Observed ORCID: 0000-0003-4569-1071
OpenAlex ID: A5111356527
Tech-driven Trust: the Role of Ai and Emerging Technologies in Pharmaceutical Quality Assurance
2025 · PAVALAN KRISHNAN, NAGARAJAN JANAKI SANKARACHARI KRISHNAN, et al. · International Journal of Applied Pharmaceutics · 7
PDF
Lifecycle Approach to Process Validation and Its Implementation in Pharmaceutical Industry
2024 · Smita Jain, Nagarajan Janaki Sankarachari Krishnan, et al. · International Journal of Pharmaceutical Quality Assurance · 3
PDF
Simultaneous Method for Quantification of Genotoxic Impurity in the Gemcitabine Hydrochloride by RP-HPLC
2019 · Samrat Debnath, Mari Raju Jeyaprakash, et al. · Journal of Young Pharmacists · 3
PDF
Data Integrity In Pharma Industry Safeguarding Trust And Compliance
2026 · Buddaraju Vivekananda Raju, B. Babu, et al. · International Journal of Drug Delivery Technology
PDF
Evaluating Data Integrity Issues in the Pharmaceutical Industry and Proposing Solutions Through the Pharmaceutical Education Curriculum.
2026 · Buddaraju Vivekananda Raju, B. Babu, et al. · International Journal of Drug Delivery Technology
PDF
Advances in Green Analytical Techniques for Impurity Profiling in Pharmaceuticals
2025 · Anamika Dey, Nagarajan Janaki Sankarachari Krishnan, et al. · Journal of Young Pharmacists
PDF
In-vivo studies of metformin modified release formulations
2020 · Nagarajan Janaki Sankarachari Krishnan, Elango Kannan · International Journal of Research in Pharmaceutical Sciences
Bioanalysis and in-vivo studies of clarithromycin modified release solid dosage formulations by liquid chromatography-mass spectroscopy
2020 · Nagarajan Janaki Sankarachari Krishnan, Elango Kannan · International Journal of Research in Pharmaceutical Sciences
Works count: 8
Citation count: 13
H-index: 3
I10-index:
Year
Topic
Type